Lingchuang Medical Valley completed nearly 200 million yuan in Series B financing.

36Kr learned from the official WeChat account of Lingchuang Medical Valley that Beijing Lingchuang Medical Valley Technology Development Co., Ltd. (hereinafter referred to as "Lingchuang Medical Valley") announced the completion of nearly 200 million yuan in Series B financing. This round of financing was jointly led by Shunxi Fund and Yizhuang Guotou, with Galaxy Innovation Capital, Guangzhou Industrial Investment Capital, and Yizhuang Investment following. Yuan Yi Capital has long served as the company's strategic advisor. The funds from this round will be mainly invested in three directions: product line expansion, production capacity upgrade, and talent and team building.